Frost & Sullivan - Articles and news items

Advanced targeted therapies dominate colorectal cancer pipeline

Industry news / 29 September 2015 / Victoria White

Advanced targeted therapies now account for 60% of the drugs under development for colorectal cancer…

Branded ACS therapies to grab market share from generic drugs

Industry news / 4 September 2015 / Victoria White

While generic acute coronary syndrome (ACS) drugs currently lead in market revenues, the share of branded therapeutics is expected to increase to more than 60% of the total market by 2019…

Turkey emerges as a global hotspot for healthcare

Industry news / 20 May 2015 / Victoria White

Driven by reforms and private investments, Turkey is steadily emerging as one of the hottest healthcare markets in the global arena…

Rising numbers of preterm births stoke demand for infant care solutions in Europe

Industry news / 23 April 2015 / Victoria White

The saturated European market for infant care solutions has received fresh impetus from the rising incidence of preterm births, reports Frost & Sullivan…

Frost & Sullivan

Targeted lung cancer therapies are supplanting conventional treatments

Industry news / 3 March 2015 / Frost & Sullivan

Close competition encourages established manufacturers to broaden the drug pipeline for targeted therapies, finds Frost & Sullivan…

Frost & Sullivan

Eastern Europe rises as the top region for healthcare investments

Industry news / 17 February 2015 / Frost & Sullivan

New Frost & Sullivan Insights uncover the booming business potential for health services in 16 countries, among which Russia, Turkey, Kazakhstan, Greece, Bulgaria and the CIS…

Frost & Sullivan

3D printing expected to go beyond market predictions across multiple industries

Industry news / 11 February 2015 / Frost & Sullivan

Amazing opportunities come along with prototyping technologies, three-dimensional (3D) printing gaining momentum across various industries from printing a mobile phone cover to reconstructing human organs…

Frost & Sullivan

European Hantavirus diagnostics market tops US market as a result of higher disease prevalence

Industry news / 28 January 2015 / Frost & Sullivan

Frost & Sullivan says existing competitors’ dominance of the niche market raises entry barriers…

Frost & Sullivan

Interoperable electronic health records can revolutionize healthcare delivery in Europe

Industry news / 27 January 2015 / Frost & Sullivan

Country-specific EHR implementation strategies will expedite market development, says Frost & Sullivan…

Frost & Sullivan

Frost & Sullivan releases drug launch and Phase 3 trial watch list for top therapeutic areas

Industry news / 13 January 2015 / Frost and Sullivan

Oncology, autoimmune and infectious diseases/vaccines are hot areas for novel therapeutics and in vitro diagnostics in 2015…

Frost & Sullivan

Medical device market ripe for investments in Eastern Europe

Industry news / 25 November 2014 / Frost & Sullivan

Frost & Sullivan profiles key medical device manufacturers in the region, where the market is expected to grow at a CAGR of 3.1 percent between 2014 and 2018…

Frost & Sullivan

Personalised care pushes US and European health providers to shift to the cloud

Industry news / 13 November 2014 / Frost & Sullivan

Cloud service providers that offer guaranteed reliability and clear data portability terms will emerge as top contenders, finds Frost & Sullivan…

  • Page 1 of 2
  • 1
  • 2
  • >


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...